Cargando…

ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development

Mechanistic studies of deregulated ERG in prostate cancer and other cancers continue to enhance its role in cancer biology and its utility as a biomarker and therapeutic target. Here, we show that ERG, through its physical interaction with androgen receptor, induces AR aggregation and endoplasmic re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sreenath, Taduru L., Macalindong, Shiela S., Mikhalkevich, Natallia, Sharad, Shashwat, Mohamed, Ahmed, Young, Denise, Borbiev, Talaibek, Xavier, Charles, Gupta, Rishita, Jamal, Muhammad, Babcock, Kevin, Tan, Shyh-Han, Nevalainen, Marja T., Dobi, Albert, Petrovics, Gyorgy, Sesterhenn, Isabell A., Rosner, Inger L., Bieberich, Charles J., Nelson, Peter, Vasioukhin, Valeri, Srivastava, Shiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430720/ https://www.ncbi.nlm.nih.gov/pubmed/28439080 http://dx.doi.org/10.1038/s41598-017-01187-4

Ejemplares similares

Erratum: ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development
por: Sreenath, Taduru L., et al.
Publicado: (2017)

Ets Family Protein, Erg Expression in Developing and Adult Mouse Tissues by a Highly Specific Monoclonal Antibody
por: Mohamed, Ahmed A., et al.
Publicado: (2010)

Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1
por: Kumar, Parameet, et al.
Publicado: (2016)

Oncogenic activation of ERG: A predominant mechanism in prostate cancer
por: Sreenath, Taduru L, et al.
Publicado: (2011)

Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN
por: Li, Hua, et al.
Publicado: (2015)

Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer
por: Sharad, Shashwat, et al.
Publicado: (2019)

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
por: Rastogi, Anshu, et al.
Publicado: (2014)

Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer
por: Sharad, Shashwat, et al.
Publicado: (2014)

PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer
por: Sharad, Shashwat, et al.
Publicado: (2020)

Prostate cancer gene expression signature of patients with high body mass index
por: Sharad, Shashwat, et al.
Publicado: (2010)

Prostate cancer marker panel with single cell sensitivity in urine
por: Nickens, Kristen P., et al.
Publicado: (2015)

Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag
por: Rastogi, Anshu, et al.
Publicado: (2016)

Focal p53 protein expression and lymphovascular invasion in primary prostate tumors predict metastatic progression
por: Gesztes, William, et al.
Publicado: (2022)

Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes
por: Kohaar, Indu, et al.
Publicado: (2022)

Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence
por: Yan, Wusheng, et al.
Publicado: (2019)

Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer
por: Thangapazham, Rajesh, et al.
Publicado: (2014)

Association of germline genetic variants with TMPRSS2-ERG fusion status in prostate cancer
por: Kohaar, Indu, et al.
Publicado: (2020)

Expression of Human Endogenous Retrovirus Group K (HERV-K) HML-2 Correlates with Immune Activation of Macrophages and Type I Interferon Response
por: Russ, Eric, et al.
Publicado: (2023)

Quantitative Expression of TMPRSS2 Transcript in Prostate Tumor Cells Reflects TMPRSS2-ERG Fusion Status
por: Mwamukonda, Kuwong, et al.
Publicado: (2009)

Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities
por: Tan, Shyh-Han, et al.
Publicado: (2018)

Age and Tumor Differentiation-Associated Gene Expression Based Analysis of Non-Familial Prostate Cancers
por: Sharad, Shashwat, et al.
Publicado: (2021)

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
por: Furusato, B, et al.
Publicado: (2010)

Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer
por: Sharad, Shashwat, et al.
Publicado: (2020)

ERG Tumor Type is Less Frequent in High Grade and High Stage Prostate Cancers of Chinese Men
por: Baohong, Jiang, et al.
Publicado: (2019)

Indocyanine Green (ICG) fluorescence angiography of gastric conduit after transhiatal thoracic esophagectomy with proximal gastrectomy for esophagogastric junction adenocarcinoma: A case report and initial experience at a tertiary government hospital in the Philippines
por: Maglangit, Sittie Aneza Camille A., et al.
Publicado: (2021)

Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells
por: Katta, Shilpa, et al.
Publicado: (2019)

Cadherin signaling: keeping cells in touch
por: Klezovitch, Olga, et al.
Publicado: (2015)

Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression
por: Gao, Yuqian, et al.
Publicado: (2020)

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
por: Kiebish, Michael A., et al.
Publicado: (2020)

Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India
por: Rawal, Sudhir, et al.
Publicado: (2013)

Recent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defects
por: Frank, Sander, et al.
Publicado: (2018)

Long noncoding RNA-mediated activation of androgen receptor in prostate cancer
por: Petrovics, Gyorgy, et al.
Publicado: (2014)

α–E-catenin binds to dynamitin and regulates dynactin-mediated intracellular traffic
por: Lien, Wen-Hui, et al.
Publicado: (2008)

Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men
por: Duncan, Allison, et al.
Publicado: (2023)

A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges
por: Kohaar, Indu, et al.
Publicado: (2019)

Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population
por: Petrovics, Gyorgy, et al.
Publicado: (2018)

Indian Herb-Derived Phytoconstituent-Based Antiviral, Antimicrobial and Antifungal Formulation: An Oral Rinse Candidate for Oral Hygiene and the Potential Prevention of COVID-19 Outbreaks
por: Sharad, Shashwat, et al.
Publicado: (2021)

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II
por: Sharad, Shashwat, et al.
Publicado: (2023)

Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men
por: Farrell, James, et al.
Publicado: (2013)

αE-catenin inhibits a Src–YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway
por: Li, Peng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o3ppianjvqqi1r1p83bkjumfq8